@article{0b087057919e45408980e989c8b1ad84,
title = "Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs",
abstract = "We used antiretroviral (ARV) drug testing to evaluate the accuracy of self-reported data for HIV status and antiretroviral treatment (ART) among people who inject drugs enrolled in an HIV prevention trial. ARV drugs were detected in enrollment samples from 72/482 = 14.9% HIV-infected participants (39/52 = 75.0% who reported being on ART; 33/430 = 7.7% who reported not being on ART). Overall, 213/482 = 44.2% participants indicated that they were not aware of their HIV-positive status prior to study entry; of those, 30 had ARV drugs detected at enrollment, including 15 who also had ARV drugs detected at the screening visit. These participants were likely aware of their HIV-positive status at study entry but did not report this to study staff. This study shows that self-reported data on HIV testing history and ART may not be accurate and that ARV drug testing can help identify persons who are aware of their HIV-positive status and are on ART.",
keywords = "ART, HIV, Indonesia, PWID, Self-report, Ukraine, Vietnam",
author = "Fogel, {Jessica M.} and Yinfeng Zhang and Palumbo, {Philip J.} and Xu Guo and William Clarke and Autumn Breaud and Paul Richardson and Estelle Piwowar-Manning and Hamilton, {Erica L.} and Ha, {Tran Viet} and Kostyantyn Dumchev and Zubairi Djoerban and Irving Hoffman and Brett Hanscom and Miller, {William C.} and Eshleman, {Susan H.}",
note = "Funding Information: The authors thank the HPTN 074 study team and participants for providing the samples and data used in this study. We also thank the laboratory staff who helped with sample management and testing. This work was supported by the HIV Prevention Trials Network (HPTN) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA), and Office of AIDS Research, of the National Institutes of Health (NIH) [UM1-AI068613 (Eshleman); UM1-AI068617 (Donnell); and UM1-AI068619 (Cohen/El-Sadr)]. Funding Information: The authors thank the HPTN 074 study team and participants for providing the samples and data used in this study. We also thank the laboratory staff who helped with sample management and testing. This work was supported by the HIV Prevention Trials Network (HPTN) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA), and Office of AIDS Research, of the National Institutes of Health (NIH) [UM1-AI068613 (Eshleman); UM1-AI068617 (Donnell); and UM1-AI068619 (Cohen/El-Sadr)]. Publisher Copyright: {\textcopyright} 2019, Springer Science+Business Media, LLC, part of Springer Nature.",
year = "2019",
month = aug,
day = "15",
doi = "10.1007/s10461-018-2379-8",
language = "English (US)",
volume = "23",
pages = "2101--2108",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "8",
}